Nicholas Investment Partners’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-56,061
Closed -$3.52M 182
2020
Q1
$3.52M Sell
56,061
-2,589
-4% -$187K 0.69% 55
2019
Q4
$4.56M Sell
58,650
-65,466
-53% -$5.11M 0.47% 66
2019
Q3
$9.1M Buy
124,116
+288
+0.2% +$20.2K 0.77% 31
2019
Q2
$7.63M Buy
123,828
+7,332
+6% +$443K 0.7% 42
2019
Q1
$7.43M Buy
116,496
+35,190
+43% +$2.01M 0.66% 29
2018
Q4
$4.15M Buy
+81,306
New +$4.11M 0.45% 75
2018
Q3
Sell
-168,420
Closed -$8.17M 224
2018
Q2
$8.17M Buy
168,420
+20,265
+14% +$946K 0.57% 35
2018
Q1
$6.89M Sell
148,155
-3,810
-3% -$165K 0.49% 40
2017
Q4
$5.71M Buy
151,965
+4,710
+3% +$173K 0.38% 69
2017
Q3
$5.37M Buy
+147,255
New +$5.62M 0.37% 76
2017
Q2
Hold
0
58
2016
Q4
Sell
-96,339
Closed -$3.87M 303
2016
Q3
$3.87M Buy
+96,339
New +$3.63M 0.26% 152
2016
Q2
Sell
-124,881
Closed -$3.67M 304
2016
Q1
$3.67M Sell
124,881
-41,391
-25% -$1.14M 0.27% 154
2015
Q4
$4.38M Sell
166,272
-10,758
-6% -$279K 0.3% 133
2015
Q3
$4.2M Sell
177,030
-1,518
-0.9% -$36.6K 0.3% 130
2015
Q2
$4.24M Buy
178,548
+74,646
+72% +$1.68M 0.27% 131
2015
Q1
$2.47M Buy
+103,902
New +$2.33M 0.15% 238

Other funds holding EW

Nicholas Investment Partners's EW Position: Q2 2020 in Review

Nicholas Investment Partners sold out of Edwards Lifesciences (EW) in Q2 2020, closing a stake of 56,061 shares — an estimated $3.52M sold.

Nicholas Investment Partners first reported a position in EW in Q1 2015 and held it in 16 quarters. The position peaked at $9.1M in Q3 2019. 1,048 funds tracked by Wall St. Rank hold EW as of Q2 2020.

  • Nicholas Investment Partners reported no remaining Edwards Lifesciences position as of Q2 2020 after selling out during the quarter.
  • Nicholas Investment Partners sold 56,061 Edwards Lifesciences shares in Q2 2020, an estimated $3.52M.
  • Nicholas Investment Partners first reported a position in Edwards Lifesciences in Q1 2015 and held it in 16 quarters.
  • Nicholas Investment Partners's Edwards Lifesciences position peaked at $9.1M in Q3 2019.
  • 1,048 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2020.

Based on Nicholas Investment Partners's 13F filing for Q2 2020, filed 12 Aug 2020.